Skip to main content
. Author manuscript; available in PMC: 2017 Nov 27.
Published in final edited form as: Immunohorizons. 2017 Nov 1;1(9):223–235. doi: 10.4049/immunohorizons.1700047

Figure 5. Effect of Depo-Provera on the susceptibility to HIV ex vivo.

Figure 5

PBMCs from study participants were exposed to HIV-1BaL (MOI 0.01) overnight. Cells were washed the following day to remove virus. The percentage of HIV p24+CD4+ T cells was determined by flow cytometry at day 10 after infection as described in methods. Wilcoxon matched-pairs signed rank test was used to compare differences between study visits of all donors (A), donors who identified as black (B), or Hispanic (C). Each dot represents one donor. Bars represent median and interquartile range. p≤0.05 was considered significant, p>0.05 was not significant (ns).